Wall Street research firms covering Aptiv have set an average price target implying a 26.6% rise from current levels, based on 25 analyst forecasts. Four analysts rate the shares as Strong Buy, 14 as Buy and seven as Hold, yielding a consensus Moderate Buy recommendation. Over the past three months, five firms have raised their targets, including Evercore ISI, which lifted its projection from $95 to $100, and Daiwa Capital Markets, which increased its forecast from $79 to $100. This cluster of upward revisions underscores growing confidence in Aptiv’s outlook among equity strategists.

In its latest quarter, Aptiv delivered earnings per share of $2.17, surpassing the consensus estimate of $1.81 by 20%. Revenue reached $5.21 billion, up 7.4% year-over-year and $160 million above analyst projections. Net margin stood at 1.46%, while return on equity climbed to 18.5%. Management has set full-year guidance at $7.55–$7.85 EPS, up from prior guidance, and forecasts fourth-quarter EPS of $1.60–$1.90. Analysts now anticipate full-year results of $7.20 per share, reflecting growing confidence in Aptiv’s ability to capitalize on its advanced driver-assistance systems and electrification product lines.

Institutional holdings have risen steadily, with hedge funds and asset managers now controlling 94.21% of outstanding shares. Notable increases include a 12.1% stake build by Hudson Bay Capital Management, which added 7,368 shares worth $5.9 million last quarter, and a 90.7% hike in holdings by Swiss Life Asset Management, representing an additional 27,844 shares valued at $5.0 million. New positions were established by Saranac Partners and Groupama Asset Management, signaling continued conviction in Aptiv’s long-term growth drivers among large-scale investors.